{"analyses":[{"ciLowerLimit":"-15","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"11","estimateComment":"The estimation parameter is based on those participants who answered they were \"very satisfied\" with overall pain control.","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","paramType":"Percent Difference","paramValue":"-2"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"34"}],"title":"Very satisfied"},{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"5"}],"title":"Somewhat satisfied"},{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"}],"title":"Neutral"},{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"}],"title":"Somewhat dissatisfied"},{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"}],"title":"Dissatisfied"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"43"}],"units":"Participants"}],"description":"-A discharge survey to document patient satisfaction and perceived pain control was given at the time of the last VAS score.","groups":[{"description":"Gabapentin liquid by mouth or per Tube 300mg twice a day","id":"OG000","title":"Gabapentin"},{"description":"Placebo liquid by mouth or Per Tube twice a day","id":"OG001","title":"Placebo"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Once on post-op day 2 or day of discharge, whichever comes first","title":"Patient Reported Post-treatment Pain Satisfaction as Measured by Overall Pain Control","type":"SECONDARY","unitOfMeasure":"Participants"}